MENLO PARK, Calif.--(BUSINESS WIRE)--Apr. 17, 2018--
Intersect ENT, Inc. (Nasdaq: XENT)
today announced that management will present at Deutsche Bank’s 43rd
Annual Health Care Conference and at Bank of America Merrill Lynch 2018
The Deutsche Bank Conference presentation is scheduled for May 9, 2018
at 10:40am EDT at the Boston InterContinental Hotel and the Bank of
America Merrill Lynch presentation is scheduled for May 16, 2018 at
4:00pm EDT at the Encore at The Wynn in Las Vegas.
A webcast of both presentations will be available online from the
Investor Relations page of the company’s website at www.IntersectENT.com.
The webcast replays will be available for approximately one month.
About Intersect ENT®
Intersect ENT is dedicated to transforming ear, nose and throat care by
providing innovative, clinically meaningful therapies to physicians and
patients. The company’s steroid releasing implants are designed to
provide mechanical spacing and deliver targeted therapy to the site of
disease. In addition, Intersect ENT is continuing to expand its
portfolio of products based on the company’s unique localized steroid
releasing technology and is committed to broadening patient access to
less invasive and more cost-effective care.
For additional information on the company or its products, including
risks and benefits, please visit www.IntersectENT.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180417005185/en/
Source: Intersect ENT, Inc.
Jeri Hilleman, 650-641-2105